Galectin Therapeutics
GALT
#8188
Rank
A$0.26 B
Marketcap
$4.19
Share price
-3.37%
Change (1 day)
40.89%
Change (1 year)

Galectin Therapeutics (GALT) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : A$0.16 Billion

According to Galectin Therapeutics's latest financial reports the company's total liabilities are A$0.16 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Galectin Therapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31A$78.58 M45.3%
2021-12-31A$54.08 M669.15%
2020-12-31A$7.03 M71.42%
2019-12-31A$4.1 M37.09%
2018-12-31A$2.99 M-21.29%
2017-12-31A$3.8 M-27.5%
2016-12-31A$5.24 M180.9%
2015-12-31A$1.86 M-10.29%
2014-12-31A$2.08 M-25.34%
2013-12-31A$2.78 M76.17%
2012-12-31A$1.58 M-26.77%
2011-12-31A$2.16 M-72.55%
2010-12-31A$7.86 M44.19%
2009-12-31A$5.45 M228.28%
2008-12-31A$1.66 M-69.11%
2007-12-31A$5.38 M-33.54%
2006-12-31A$8.09 M329.46%
2005-12-31A$1.88 M45.22%
2004-12-31A$1.29 M155.38%
2003-12-31A$0.5 M-57.03%
2002-12-31A$1.18 M9.68%
2001-12-31A$1.07 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$0.28 B 66.88%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.03 B 509.84%๐Ÿ‡บ๐Ÿ‡ธ USA